09/18/2026
Recent research has linked gabapentin to early-onset dementia and cognitive impairment. These concerns have also led to lawsuits alleging that manufacturers failed to adequately warn patients and healthcare providers about potential risks with this drug.
See if you qualify for compensation on our website: https://www.masstortreport.com/blog/the-hidden-risk-of-a-common-medication-why-manufacturers-of-gabapentin-are-under-fire-amid-dementia-claims.html